Regenexx, LLC

DES MOINES, IA · Founded 2017 · CIK 0001712780 · Medtech · Private

Regenerative medicine procedures using patient-derived cells (stem cells and platelets) for joint and orthopedic treatment

regenexx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$10M
1 Form D · Jul 2017
111 months since last filing
Contracts
—
No federal contracts on record
Patents
14
4 granted · 10 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$10,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2158CONSTANTIAM BIOSCIENCES INC.——
2159STYLOSONIC LLC——
2160JELIKALITE LLC——
2161Regenexx, LLC—$10M
2162Moai Technologies L.L.C.——
2163FILTRO MEDICAL INC.——
2164NANOMAG LLC—$4.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Chris CentenoDirector · Executive Officer
  • Jason HellicksonDirector · Executive Officer
  • Andrew IttlemanDirector
  • Thomas JackowskiDirector
  • Reiner KremerDirector

Patents

USPTO · 4 granted of 14

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.